Insulet (PODD) Tops Q2 EPS by 25c
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $134.68 -2.35%
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of $1.17, $0.25 better than the analyst estimate of $0.92. Revenue for the quarter came in at $649.1 million versus the consensus estimate of $614.18 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- Openai Is Open To Slowing Cutting-edge Ai, Altman Tells Staff - Bloomberg
- Vistra prices $1.5B junior subordinated notes offering due 2057
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
